Rekah Pharmaceutical Industry Ltd. (TLV:REKA)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
1,286.00
-118.00 (-8.40%)
Apr 29, 2025, 5:32 PM IDT

TLV:REKA Ratios and Metrics

Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
147151169176266306
Upgrade
Market Cap Growth
-10.35%-10.35%-3.96%-33.89%-13.13%34.20%
Upgrade
Enterprise Value
274295338321420441
Upgrade
Last Close Price
12.8613.2514.7815.3922.4025.79
Upgrade
PE Ratio
23.8124.37--40.1228.33
Upgrade
PS Ratio
0.460.470.520.601.011.15
Upgrade
PB Ratio
0.910.931.081.081.541.85
Upgrade
P/TBV Ratio
1.451.501.901.391.901.90
Upgrade
P/FCF Ratio
8.228.4710.015.4834.59-
Upgrade
P/OCF Ratio
5.535.705.954.5012.5527.11
Upgrade
EV/Sales Ratio
0.850.921.051.101.591.66
Upgrade
EV/EBITDA Ratio
10.8817.0513.007.8711.7310.86
Upgrade
EV/EBIT Ratio
--116.4324.2032.4921.10
Upgrade
EV/FCF Ratio
15.3516.5320.0710.0054.61-
Upgrade
Debt / Equity Ratio
0.830.831.181.020.961.00
Upgrade
Debt / EBITDA Ratio
5.335.335.614.074.644.10
Upgrade
Debt / FCF Ratio
7.527.5210.895.1721.59-
Upgrade
Asset Turnover
0.690.690.690.660.620.68
Upgrade
Inventory Turnover
2.792.792.562.352.122.36
Upgrade
Quick Ratio
0.900.901.011.061.301.17
Upgrade
Current Ratio
1.451.451.751.752.252.10
Upgrade
Return on Equity (ROE)
3.91%3.91%-4.35%-1.22%3.91%6.73%
Upgrade
Return on Assets (ROA)
-0.98%-0.98%0.39%1.87%1.88%3.32%
Upgrade
Return on Capital (ROIC)
-1.44%-1.44%0.55%2.48%2.41%4.14%
Upgrade
Return on Capital Employed (ROCE)
--0.90%4.30%3.80%6.70%
Upgrade
Earnings Yield
4.23%4.10%-4.10%-1.16%2.49%3.53%
Upgrade
FCF Yield
12.16%11.80%9.99%18.25%2.89%-2.40%
Upgrade
Dividend Yield
----3.87%-
Upgrade
Total Shareholder Return
----3.87%-
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.